Cocrystal Pharma (COCP) Retained Earnings (2010 - 2026)
Cocrystal Pharma (COCP) reported Retained Earnings of -$344.5 million for Q1 2026, down 2.63% on a YoY basis from -$353.9 million in Q1 2025, and down 0.67% sequentially from -$342.2 million in Q4 2025.
Cocrystal Pharma (COCP) Retained Earnings (2010 - 2026) Analysis & Trends
Cocrystal Pharma (COCP) has 17 years of Retained Earnings data on file, last reported at -$344.5 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 2.63% year-over-year to -$344.5 million; the trailing twelve-month figure through Mar 2026 stood at -$344.5 million (down 2.63% YoY), and the FY2025 full-year result was -$342.2 million, down 2.65% from the prior year.
- Retained Earnings declined to -$344.5 million in Q1 2026, from -$342.2 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$263.3 million in Q1 2022 to a low of -$344.5 million in Q1 2026.
- A 5-year average of -$317.0 million and a median of -$319.9 million in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings fell 15.12% in 2023 and decreased 2.63% in 2026, its largest moves.
- Tracing COCP's Retained Earnings over 5 years: stood at -$297.9 million in 2022, then declined by 6.04% to -$315.9 million in 2023, then declined by 5.54% to -$333.4 million in 2024, then decreased by 2.65% to -$342.2 million in 2025, then retreated by 0.67% to -$344.5 million in 2026.
- Business Quant data shows COCP's Retained Earnings at -$344.5 million in Q1 2026, -$342.2 million in Q4 2025, and -$339.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -622,000.00 |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | -344.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -344.55 Mn |
| Dec 31, 2025 | -342.25 Mn |
| Sep 30, 2025 | -339.82 Mn |
| Jun 30, 2025 | -337.77 Mn |
| Mar 31, 2025 | -335.72 Mn |
| Dec 31, 2024 | -333.42 Mn |
| Sep 30, 2024 | -330.15 Mn |
| Jun 30, 2024 | -325.21 Mn |
| Mar 31, 2024 | -319.87 Mn |
| Dec 31, 2023 | -315.91 Mn |
| Sep 30, 2023 | -311.45 Mn |
| Jun 30, 2023 | -307.29 Mn |
| Mar 31, 2023 | -303.12 Mn |
| Dec 31, 2022 | -297.93 Mn |
| Sep 30, 2022 | -293.43 Mn |
| Jun 30, 2022 | -287.73 Mn |
| Mar 31, 2022 | -263.30 Mn |
| Dec 31, 2021 | -259.09 Mn |
| Sep 30, 2021 | -255.41 Mn |
| Jun 30, 2021 | -251.47 Mn |